For further details see:
Johnson & Johnson (NYSE:JNJ) Promises Enough COVID-19 Vaccine Doses For Americans By SpringFor further details see:
Johnson & Johnson (NYSE:JNJ) Promises Enough COVID-19 Vaccine Doses For Americans By SpringMarket Wire News is a media platform, the information on this page was provided by Wall Street PR via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant-eligible PR Newswire Findings from first-ever quadruplet therapy study with subcutaneous DARZALE...
Johnson & Johnson (NYSE: JNJ) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5 th , at the Encore Boston Harbor, Evertte, MA. Tim Schmid, Executive Vice President, WorldWide Chairman, MedTech will represent the Company in a session scheduled at 11:00...
2024-07-27 06:35:00 ET One of the biggest risks facing Johnson & Johnson (NYSE: JNJ) in recent years has been its exposure to talc lawsuits. The uncertainty around that issue is a key reason why shares of Johnson & Johnson have declined by 9% in the past three years, with ...